ClinicalTrials.gov record
Completed No phase listed Observational

Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions

ClinicalTrials.gov ID: NCT01609621

Public ClinicalTrials.gov record NCT01609621. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 2:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01609621
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Cook Group Incorporated
Industry
Enrollment
199 participants

Conditions and interventions

Interventions

  • Retrograde tibiopedal arterial access Device

Device

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2012
Primary completion
Jun 30, 2013
Completion
Jul 31, 2013
Last update posted
Nov 16, 2020

2012 – 2013

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Interventional Technologies, LLC (Tucson Medical Center) Tucson Arizona 85712
MedStar Health Research Institute (Washington Hospital Center) Washington D.C. District of Columbia 20010
First Coast Cardiovascular Institute Jacksonville Florida 32216
University of Miami (Mount Sinai Hospital) Miami Florida 33140
Terrebone Medical Center Houma Louisiana 70360
Metro Heart and Vascular Wyoming Michigan 49519
Rex Hospital, Inc Raleigh North Carolina 27607
CAMC Health Education and Research Institute, Inc. Charleston West Virginia 25304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01609621, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2020 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01609621 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →